The market may attempt a bounce back considering the oversold conditions, but it is unlikely to sustain the same. Below are ...
MSD’s play for Harpoon Therapeutics had been rumoured ahead of the announcement and was confirmed today as a $23-per-share offer that values the company at $680 million. It gives MSD (known as ...
Her work is featured in leading publications across various industries, including Wealth Rocket, CryptoVantage, and Sta... Candice Reeves is a financial writer based out of Nova Scotia.